bioRxiv·2 OctSotagliflozin Reprograms Hepatic Lipid Metabolism and Attenuates Atherosclerosis Beyond Empagliflozin in CKM MicePreprint: experiments in miceAtherosclerosisPaper
ADA Scientific Sessions 2026 Abstract·5 JunFasting Reveals Tissue-Specific Dysregulation of De Novo Lipogenesis in Diabetic MiceExperiments in animalsMechanismsPaper
ADA Scientific Sessions 2025 Abstract·13 JunAssociation of the Genetic Variant Rs10911021 with Coronary Artery Calcium Score Is Mediated by Alterations of Glutamic Acid Metabolism in Individuals with Type 2 DiabetesStudy in peopleMechanismsPaper
ADA Scientific Sessions 2025 Abstract·13 JunMetabotypes to Define Cardiorenal Risk in People with Type 1 DiabetesStudy in peopleBiomarkersPaper
ADA Scientific Sessions 2025 Abstract·13 JunThe Ketone Body β-hydroxybutyrate Mitigates Diabetic Kidney Disease through Metabolic ReprogrammingExperiments in animalsInterventionsPaper